These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36792176)

  • 1. A questionnaire-based survey of medical conditions in adults with Prader-Willi syndrome in Japan: implications for transitional care.
    Kawai M; Muroya K; Murakami N; Ihara H; Takahashi Y; Horikawa R; Ogata T
    Endocr J; 2023 May; 70(5):519-528. PubMed ID: 36792176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment.
    Pellikaan K; Rosenberg AGW; Kattentidt-Mouravieva AA; Kersseboom R; Bos-Roubos AG; Veen-Roelofs JMC; van Wieringen N; Hoekstra FME; van den Berg SAA; van der Lely AJ; de Graaff LCG
    J Clin Endocrinol Metab; 2020 Dec; 105(12):e4671-87. PubMed ID: 32877518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.
    Yang A; Kim J; Cho SY; Jin DK
    Orphanet J Rare Dis; 2017 Aug; 12(1):146. PubMed ID: 28854950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
    Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
    J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prader-Willi syndrome and growth hormone deficiency.
    Aycan Z; Baş VN
    J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study.
    Fintini D; Grugni G; Bocchini S; Brufani C; Di Candia S; Corrias A; Delvecchio M; Salvatoni A; Ragusa L; Greggio N; Franzese A; Scarano E; Trifirò G; Mazzanti L; Chiumello G; Cappa M; Crinò A;
    Nutr Metab Cardiovasc Dis; 2016 Sep; 26(9):842-7. PubMed ID: 27381990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric behavioral effect and characteristics of type 2 diabetes mellitus on Japanese patients with Prader-Willi syndrome: a preliminary retrospective study.
    Oto Y; Murakami N; Inoue T; Matsubara K; Saima S; Ogata H; Ihara H; Nagai T; Matsubara T
    J Pediatr Endocrinol Metab; 2022 Jan; 35(1):89-96. PubMed ID: 34792304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Italian National Survey for Prader-Willi syndrome: an epidemiologic study.
    Grugni G; Crinò A; Bosio L; Corrias A; Cuttini M; De Toni T; Di Battista E; Franzese A; Gargantini L; Greggio N; Iughetti L; Livieri C; Naselli A; Pagano C; Pozzan G; Ragusa L; Salvatoni A; Trifirò G; Beccaria L; Bellizzi M; Bellone J; Brunani A; Cappa M; Caselli G; Cerioni V; Delvecchio M; Giardino D; Iannì F; Memo L; Pilotta A; Pomara C; Radetti G; Sacco M; Sanzari A; Sartorio A; Tonini G; Vettor R; Zaglia F; Chiumello G;
    Am J Med Genet A; 2008 Apr; 146A(7):861-72. PubMed ID: 18203198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.
    Damen L; Grootjen LN; Donze SH; Juriaans AF; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):439-448. PubMed ID: 32609902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the value of growth hormone therapy in Prader Willi syndrome?
    Bridges N
    Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral adipose tissue resides within the reference range in children with Prader-Willi syndrome receiving nutritional intervention on a regular basis.
    Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
    Endocr J; 2020 Oct; 67(10):1029-1037. PubMed ID: 32565499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
    Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome.
    Shukur HH; Hussain-Alkhateeb L; Farholt S; Nørregaard O; Jørgensen AP; Hoybye C
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3634-e3643. PubMed ID: 33950234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of medical care and the prevalence of serious illness in an adult Prader-Willi syndrome cohort.
    Sinnema M; Maaskant MA; van Schrojenstein Lantman-de Valk HM; Boer H; Curfs LM; Schrander-Stumpel CT
    Eur J Med Genet; 2013 Aug; 56(8):397-403. PubMed ID: 23792791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive team approach to the management of patients with Prader-Willi syndrome.
    Eiholzer U; Whitman BY
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1153-75. PubMed ID: 15506675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
    Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
    Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
    Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Prader-Willi Syndrome (PWS) in adults - what an endocrinologist needs to know. Recommendations of the Polish Society of Endocrinology and the Polish Society of Paediatric Endocrinology and Diabetology.
    Góralska M; Bednarczuk T; Rosłon M; Libura M; Szalecki M; Hilczer M; Stawerska R; Smyczyńska J; Karbownik-Lewińska M; Walczak M; Lewiński A
    Endokrynol Pol; 2018; 69(4):. PubMed ID: 30209801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.